DM
Deerfield Management Portfolio holdings
AUM
$6.52B
1-Year Est. Return
13.67%
1 Year Est. Return
+13.67%
AUM
$6.52B
AUM Growth
+$1.02B
(+18%)
Holding
173
Top Buys
| 1 | +$209M | |
| 2 | +$130M | |
| 3 | +$105M | |
| 4 |
Cogent Biosciences
COGT
|
+$92.1M |
| 5 |
Inspire Medical Systems
INSP
|
+$67.4M |
Top Sells
| 1 | +$250M | |
| 2 | +$86.3M | |
| 3 | +$48.1M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$48M |
| 5 |
Baxter International
BAX
|
+$42.8M |
Sector Composition
| 1 | Healthcare | 91.92% |
| 2 | Real Estate | 0.38% |
| 3 | Financials | 0.07% |
| 4 | Consumer Staples | 0.07% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bio-Rad Laboratories Class A
BIO
$8.59B
| $63.4M | 0.97% |
226,070
|
|
||
27
Pharvaris
PHVS
$1.57B
| $60.9M | 0.93% |
2,442,464
+425,000
|
|
||
28
Disc Medicine
IRON
$3.39B
| $60.8M | 0.93% |
919,403
|
|
||
|
29
IDEAYA Biosciences
IDYA
$2.95B
| $58.6M | 0.89% |
2,153,043
-1,762,268
|
|
||
|
BBOT
30
BridgeBio Oncology
BBOT
$908M
| $56.6M | 0.86% |
+4,885,446
|
|
||
31
Envista
NVST
$3.32B
| $46.7M | 0.71% |
2,294,036
+78,191
|
|
||
32
Praxis Precision Medicines
PRAX
$4.48B
| $44.6M | 0.68% |
840,851
+153,920
|
|
||
33
CorMedix
CRMD
$771M
| $38.7M | 0.59% |
+3,323,833
|
|
||
34
Enhabit
EHAB
$481M
| $38M | 0.58% |
4,747,746
-32,118
|
|
||
35
Embecta
EMBC
$720M
| $37M | 0.56% |
2,620,421
-129,291
|
|
||
36
Celcuity
CELC
$4.51B
| $36.2M | 0.55% |
+733,530
|
|
||
37
CONMED
CNMD
$1.36B
| $35.8M | 0.55% |
760,196
+59,925
|
|
||
|
ZBIO
38
Zenas BioPharma
ZBIO
$1.85B
| $34.7M | 0.53% |
1,562,942
|
|
||
39
NeoGenomics
NEO
$1.56B
| $34.3M | 0.52% |
4,447,331
+2,299,331
|
|
||
40
Arrowhead Research
ARWR
$7.87B
| $34.2M | 0.52% |
+993,000
|
|
||
41
Day One Biopharmaceuticals
DAWN
$866M
| $33.2M | 0.51% |
4,705,413
+982,282
|
|
||
42
Kymera Therapeutics
KYMR
$4.62B
| $32.4M | 0.49% |
572,258
-80,742
|
|
||
43
CareDx
CDNA
$897M
| $31.9M | 0.49% |
+2,191,000
|
|
||
44
Alnylam Pharmaceuticals
ALNY
$61.4B
| $31M | 0.47% |
67,935
-77,065
|
|
||
45
Acadia Healthcare
ACHC
$1.49B
| $29.4M | 0.45% |
+1,189,000
|
|
||
|
SION
46
Sionna Therapeutics
SION
$1.74B
| $28.5M | 0.44% |
970,590
|
|
||
47
Savara
SVRA
$1.18B
| $28.4M | 0.43% |
7,964,000
|
|
||
48
Phreesia
PHR
$1.21B
| $26.3M | 0.4% |
1,116,752
+102,175
|
|
||
49
Veracyte
VCYT
$3.65B
| $24.9M | 0.38% |
726,000
+101,000
|
|
||
50
Ventas
VTR
$37.6B
| $24.8M | 0.38% |
354,000
|
|